Title: Campbell JE, et al. EPZ011989, A Potent, Orally-Available EZH2 Inhibitor with Robust in Vivo Activity. ACS Med Chem Lett. 2015 Mar 4;6(5):491-495.
1598383-40-4
17205-02-6 | Ethyl 3-hydroxycyclobutanecarboxylate | AA00ABQX | MFCD09758972
152126-30-2 | 3-Fluoroisonicotinamide | AA00AC0W | MFCD11521280
1710-66-3 | (Isothiazol-5-yl)methanol | AA00ACAW | MFCD16497122
15093-42-2 | 1-Phenethyl-3-phenylthiourea | AA00ACQ5 | MFCD00022124
165558-79-2 | 4-Pyridinemethanamine,N,2-dimethyl-(9CI) | AA00ACVN | MFCD09864373
151636-94-1 | 10-Dehydrobaccatin V | AA00AD39
180915-78-0 | rac-Lasofoxifene | AA00AD9R | MFCD00949977
197587-31-8 | HEPTAKIS(6-O-SULFO)-(BETA)-CYCLODEXTRIN | AA00ADFW | MFCD03095521
172430-46-5 | O-Desaryl Ranolazine | AA00ADOP | MFCD18252412
196200-04-1 | tert-Butyl N-[2-(dimethylamino)ethyl]carbamate | AA00ADWB | MFCD08729296